Tikcro Technologies Ltd. (TIKRF) Research
Tikcro Technologies Ltd., an Israeli enterprise, is primarily involved in advancing biotechnology projects. Among its offerings is anti-cytotoxic T-lymphocyte-associated protein 4, which is utilized for immunotherapeutic approaches to cancer. The company, established in 1999, was previously known as Tioga Technologies Ltd. before rebranding to its current name in September 2003. Its main office is located in Hadera, Israel.
Market snapshot
- Symbol
- TIKRF
- Price
- $0.11
- Day change
- 0.00%
- Market cap
- $1.1M
- P/E ratio
- -2.27x
- 52-week range
- 0.05-0.3
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
Recent insider activity
- BRONSON STEVEN N — P-Purchase (36506 shares) on 2006-10-18
- BRONSON STEVEN N — P-Purchase (65969 shares) on 2006-08-11
- BRONSON STEVEN N — P-Purchase (65655 shares) on 2006-07-14
- BRONSON STEVEN N — P-Purchase (184813 shares) on 2006-05-25
- BRONSON STEVEN N — P-Purchase (86257 shares) on 2006-04-25
Open Tikcro Technologies Ltd. (TIKRF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.